KEGG   DISEASE: Familial hypercholesterolemia
Entry
H00155                      Disease                                
Name
Familial hypercholesterolemia;
Autosomal dominant hypercholesterolaemia
  Subgroup
Familial autosomal recessive hypercholesterolemia [DS:H01918]
  Supergrp
Hyperlipidemia [DS:H01635]
Description
Familial hypercholesterolaemia (FHCL) is an autosomal dominant disorder caused by deficiency of low density lipoprotein receptor. Other forms of this disorder include hypercholesterolemia caused by mutation of APOB or PCSK9 gene. This disorder is characterized by severely elevated plasma LDL cholesterol, tuberous and tendon xanthomata, and premature atherosclerosis. Patients have a significantly elevated risk of early coronary heart disease.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Disorders of lipoprotein metabolism or certain specified lipidaemias
    5C80  Hyperlipoproteinaemia
     H00155  Familial hypercholesterolemia
Pathway-based classification of diseases [BR:br08402]
 Endocrine system
  nt06324  GHRH-GH-IGF signaling
   H00155  Familial hypercholesterolemia
  nt06320  APOB-LDLR signaling
   H00155  Familial hypercholesterolemia
Pathway
hsa04979  Cholesterol metabolism
hsa04975  Fat digestion and absorption
hsa04900  Neuroendocrine signaling pathway of hypothalamus-pituitary axis
Network
nt06320 APOB-LDLR signaling
nt06324 GHRH-GH-IGF signaling
Gene
(FHCL1) LDLR [HSA:3949] [KO:K12473]
(FHCL1) EPHX2 [HSA:2053] [KO:K08726]
(FHCL1) GHR [HSA:2690] [KO:K05080]
(FHCL1) PPP1R17 [HSA:10842] [KO:K08067]
(FHCL1) APOA2 [HSA:336] [KO:K08758]
(FHCL2) APOB [HSA:338] [KO:K14462]
(FHCL3) PCSK9 [HSA:255738] [KO:K13050]
(FHCL4) LDLRAP1 [HSA:26119] [KO:K12474]
Drug
Simvastatin [DR:D00434]
Pravastatin sodium [DR:D00893]
Fluvastatin sodium [DR:D00892] (Heterozygous familial)
Atorvastatin calcium [DR:D02258]
Rosuvastatin calcium [DR:D01915]
Ezetimibe [DR:D01966]
Mipomersen sodium [DR:D08946]
Lomitapide mesylate [DR:D09638]
Evolocumab [DR:D10557]
Alirocumab [DR:D10335]
Bempedoic acid [DR:D10691]
Inclisiran [DR:D11931]
Inclisiran sodium [DR:D12293]
Evinacumab [DR:D11753]
Lerodalcibep [DR:D13095]
Niacin and lovastatin [DR:D10292]
Ezetimibe and simvastatin [DR:D10257]
Bempedoic acid and ezetimibe [DR:D11794]
Ezetimibe and rosuvastatin [DR:D11520]
Enlicitide decanoate [DR:D13186]
Other DBs
ICD-11: 5C80.00
MeSH: D006937
OMIM: 143890 144010 603776 603813
Reference
  Authors
Humphries SE, Norbury G, Leigh S, Hadfield SG, Nair D
  Title
What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?
  Journal
Curr Opin Lipidol 19:362-8 (2008)
DOI:10.1097/MOL.0b013e32830636e5
Reference
  Authors
Newson AJ, Humphries SE
  Title
Cascade testing in familial hypercholesterolaemia: how should family members be contacted?
  Journal
Eur J Hum Genet 13:401-8 (2005)
DOI:10.1038/sj.ejhg.5201360
Reference
  Authors
Hadfield SG, Humphries SE
  Title
Implementation of cascade testing for the detection of familial hypercholesterolaemia.
  Journal
Curr Opin Lipidol 16:428-33 (2005)
DOI:10.1097/01.mol.0000174152.76554.d6
Reference
PMID:11389828 (LDLR)
  Authors
Koivisto UM, Hubbard AL, Mellman I
  Title
A novel cellular phenotype for familial hypercholesterolemia due to a defect in polarized targeting of LDL receptor.
  Journal
Cell 105:575-85 (2001)
DOI:10.1016/s0092-8674(01)00371-3
Reference
PMID:14673705 (EPHX2)
  Authors
Sato K, Emi M, Ezura Y, Fujita Y, Takada D, Ishigami T, Umemura S, Xin Y, Wu LL, Larrinaga-Shum S, Stephenson SH, Hunt SC, Hopkins PN
  Title
Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.
  Journal
J Hum Genet 49:29-34 (2004)
DOI:10.1007/s10038-003-0103-6
Reference
PMID:12910492 (GHR)
  Authors
Takada D, Ezura Y, Ono S, Iino Y, Katayama Y, Xin Y, Wu LL, Larringa-Shum S, Stephenson SH, Hunt SC, Hopkins PN, Emi M
  Title
Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred.
  Journal
Am J Med Genet A 121A:136-40 (2003)
DOI:10.1002/ajmg.a.20172
Reference
PMID:12955585 (PPP1R17)
  Authors
Ono S, Ezura Y, Emi M, Fujita Y, Takada D, Sato K, Ishigami T, Umemura S, Takahashi K, Kamimura K, Bujo H, Saito Y
  Title
A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia.
  Journal
J Hum Genet 48:447-450 (2003)
DOI:10.1007/s10038-003-0055-x
Reference
PMID:12522687 (APOA2)
  Authors
Takada D, Emi M, Ezura Y, Nobe Y, Kawamura K, Iino Y, Katayama Y, Xin Y, Wu LL, Larringa-Shum S, Stephenson SH, Hunt SC, Hopkins PN
  Title
Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
  Journal
J Hum Genet 47:656-64 (2002)
DOI:10.1007/s100380200101
Reference
PMID:10952765 (APOB)
  Authors
Saint-Jore B, Varret M, Dachet C, Rabes JP, Devillers M, Erlich D, Blanchard P, Krempf M, Mathe D, Chanu B, Jacotot B, Farnier M, Bonaiti-Pellie C, Junien C, Boileau C
  Title
Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
  Journal
Eur J Hum Genet 8:621-30 (2000)
DOI:10.1038/sj.ejhg.5200516
Reference
PMID:12730697 (PCSK9)
  Authors
Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C
  Title
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
  Journal
Nat Genet 34:154-6 (2003)
DOI:10.1038/ng1161
Reference
PMID:12016260 (LDLRAP1)
  Authors
Al-Kateb H, Bahring S, Hoffmann K, Strauch K, Busjahn A, Nurnberg G, Jouma M, Bautz EK, Dresel HA, Luft FC
  Title
Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia.
  Journal
Circ Res 90:951-8 (2002)
DOI:10.1161/01.res.0000018002.43041.08
LinkDB

» Japanese version

KEGG   DISEASE: Growth hormone deficiency
Entry
H00254                      Disease                                
Name
Growth hormone deficiency;
Pituitary dwarfism
  Subgroup
Isolated growth hormone deficiency (IGHD) [DS:H02035]
Combined pituitary hormone deficiency (CPHD) [DS:H02036]
Laron syndrome (PD2) [DS:H02037]
X-linked panhypopituitarism (PHPX) [DS:H02038]
Kowarski syndrome [DS:H02039]
Growth hormone deficiency, isolated partial (GHDP)
Growth hormone insensitivity, partial (GHIP)
  Supergrp
Hypopituitarism [DS:H01700]
Description
Growth hormone deficiency, formerly known as Pituitary dwarfism, is a heterogeneous condition characterized by growth retardation with short stature and normal body proportions caused by growth hormone deficiency.
Category
Endocrine and metabolic disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Endocrine diseases
   Disorders of the pituitary hormone system
    5A61  Hypofunction or certain other specified disorders of pituitary gland
     H00254  Growth hormone deficiency
Pathway-based classification of diseases [BR:br08402]
 Immune system
  nt06537  TCR/BCR signaling
   H00254  Growth hormone deficiency
 Endocrine system
  nt06324  GHRH-GH-IGF signaling
   H00254  Growth hormone deficiency
Pathway
hsa04662  B cell receptor signaling pathway
hsa04935  Growth hormone synthesis, secretion and action
hsa04080  Neuroactive ligand-receptor interaction
hsa04900  Neuroendocrine signaling pathway of hypothalamus-pituitary axis
Network
nt06324 GHRH-GH-IGF signaling
nt06537 TCR/BCR signaling
Gene
(IGHD1A/1B/2) GH1 [HSA:2688] [KO:K05438]
(IGHD3) BTK [HSA:695] [KO:K07370]
(IGHD4) GHRHR [HSA:2692] [KO:K04584]
(CPHD1) POU1F1 [HSA:5449] [KO:K09363]
(CPHD2) PROP1 [HSA:5626] [KO:K09327]
(CPHD3) LHX3 [HSA:8022] [KO:K09374]
(CPHD4) LHX4 [HSA:89884] [KO:K09374]
(CPHD5) HESX1 [HSA:8820] [KO:K09354]
(CPHD6) OTX2 [HSA:5015] [KO:K18490]
(CPHD7/IGHD5) RNPC3 [HSA:55599] [KO:K13157]
(CPHD8) ROBO1 [HSA:6091] [KO:K06753]
(PD2/GHIP) GHR [HSA:2690] [KO:K05080]
(PHPX) SOX3 [HSA:6658] [KO:K09267]
(GHDP) GHSR [HSA:2693] [KO:K04284]
Drug
Somatropin [DR:D02691]
Somapacitan [DR:D11194]
Somatrogon [DR:D10990]
Lonapegsomatropin [DR:D11486]
Other DBs
ICD-11: 5A61.0 5A61.3
MeSH: D004393
OMIM: 615925 604271
Reference
PMID:7868072
  Authors
Perez Jurado LA, Argente J
  Title
Molecular basis of familial growth hormone deficiency.
  Journal
Horm Res 42:189-97 (1994)
DOI:10.1159/000184192
Reference
PMID:9799079
  Authors
Procter AM, Phillips JA 3rd, Cooper DN
  Title
The molecular genetics of growth hormone deficiency.
  Journal
Hum Genet 103:255-72 (1998)
DOI:10.1007/s004390050815
Reference
  Authors
Hayashi Y, Kamijo T, Ogawa M, Seo H
  Title
Familial isolated growth hormone deficiency: genetics and pathophysiology.
  Journal
Endocr J 49:265-72 (2002)
DOI:10.1507/endocrj.49.265
Reference
  Authors
Hernandez LM, Lee PD, Camacho-Hubner C
  Title
Isolated growth hormone deficiency.
  Journal
Pituitary 10:351-7 (2007)
DOI:10.1007/s11102-007-0073-3
Reference
  Authors
Mullis PE
  Title
Genetics of growth hormone deficiency.
  Journal
Endocrinol Metab Clin North Am 36:17-36 (2007)
DOI:10.1016/j.ecl.2006.11.010
Reference
PMID:8488849 (GHR)
  Authors
Berg MA, Argente J, Chernausek S, Gracia R, Guevara-Aguirre J, Hopp M, Perez-Jurado L, Rosenbloom A, Toledo SP, Francke U
  Title
Diverse growth hormone receptor gene mutations in Laron syndrome.
  Journal
Am J Hum Genet 52:998-1005 (1993)
Reference
PMID:12428212 (SOX3)
  Authors
Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, Raynaud M, Paringaux C, Van Bokhoven H, Kalscheuer V, Fryns JP, Chelly J, Moraine C, Briault S
  Title
Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency.
  Journal
Am J Hum Genet 71:1450-5 (2002)
DOI:10.1086/344661
Reference
PMID:16511605 (GHSR)
  Authors
Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S
  Title
Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature.
  Journal
J Clin Invest 116:760-8 (2006)
DOI:10.1172/JCI25303
Reference
PMID:7565946 (GHIP)
  Authors
Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM
  Title
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
  Journal
N Engl J Med 333:1093-8 (1995)
DOI:10.1056/NEJM199510263331701
LinkDB

» Japanese version

KEGG   DISEASE: Laron syndrome
Entry
H02037                      Disease                                
Name
Laron syndrome;
Growth hormone insensitivity syndrome;
Pituitary dwarfism II
  Supergrp
Growth hormone deficiency [DS:H00254]
Hypopituitarism [DS:H01700]
Description
Laron syndrome is a rare autosomal recessive disease characterized by insensitivity to growth hormone (GH). The disorder is caused by mutations of the gene encoding the GH receptor (GHR), leading to defective functioning of the GH-IGF1 signalling pathway. The main phenotypic feature is dwarfism, noticeable from birth. Patients have an elevated level of GH and undetectable, or very low IGF1 concentrations in serum.
Category
Endocrine and metabolic disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Endocrine diseases
   Disorders of the pituitary hormone system
    5A61  Hypofunction or certain other specified disorders of pituitary gland
     H02037  Laron syndrome
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06518  JAK-STAT signaling
   H02037  Laron syndrome
 Endocrine system
  nt06324  GHRH-GH-IGF signaling
   H02037  Laron syndrome
Pathway
hsa04630  JAK-STAT signaling pathway
hsa04935  Growth hormone synthesis, secretion and action
hsa04900  Neuroendocrine signaling pathway of hypothalamus-pituitary axis
Network
nt06324 GHRH-GH-IGF signaling
nt06518 JAK-STAT signaling
Gene
GHR [HSA:2690] [KO:K05080]
Other DBs
ICD-11: 5A61.0
MeSH: D046150
OMIM: 262500
Reference
  Authors
Janecka A, Kolodziej-Rzepa M, Biesaga B
  Title
Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
  Journal
In Vivo 30:375-81 (2016)
Reference
PMID:8450064 (GHR)
  Authors
Edery M, Rozakis-Adcock M, Goujon L, Finidori J, Levi-Meyrueis C, Paly J, Djiane J, Postel-Vinay MC, Kelly PA
  Title
Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
  Journal
J Clin Invest 91:838-44 (1993)
DOI:10.1172/JCI116304
LinkDB

» Japanese version

DBGET integrated database retrieval system